Shingles (Herpes Zoster) Vaccine (Zostavax(®)): A Review in the Prevention of Herpes Zoster and Postherpetic Neuralgia.
about
A universal mammalian vaccine cell line substrate.Human cytomegalovirus vaccine development: Immune responses to look into vaccine strategy.Herpes zoster chronification to postherpetic neuralgia induces brain activity and grey matter volume change.Altered functional connectivity density in patients with herpes zoster and postherpetic neuralgia.The effect and safety of ozone autohemotherapy combined with pharmacological therapy in postherpetic neuralgia
P2860
Shingles (Herpes Zoster) Vaccine (Zostavax(®)): A Review in the Prevention of Herpes Zoster and Postherpetic Neuralgia.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Shingles (Herpes Zoster) Vacci ...... er and Postherpetic Neuralgia.
@en
type
label
Shingles (Herpes Zoster) Vacci ...... er and Postherpetic Neuralgia.
@en
prefLabel
Shingles (Herpes Zoster) Vacci ...... er and Postherpetic Neuralgia.
@en
P2860
P1433
P1476
Shingles (Herpes Zoster) Vacci ...... er and Postherpetic Neuralgia.
@en
P2860
P2888
P304
P356
10.1007/S40259-016-0180-7
P577
2016-05-17T00:00:00Z